Brazilian Medicine Angioplasty or Surgery Study (MASS) finds little difference between angina therapies:
This article was originally published in Clinica
Executive Summary
Bypass surgery patients were less likely to need revascularisation than those treated by PTCA or medication in the Brazilian Medicine Angioplasty or Surgery Study (MASS). None of the bypass patients needed revascularisation during a three-year follow-up period. All three strategies eventually eradicating limiting-angina but bypass and angioplasty gave greater initial relief and better treadmill test scores. There was no difference in mortality or infarction rates, says Dr Whady Hueb, writing in the Journal of the American College of Cardiology (December).
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.